SIGMA Brand
Displaying 149401-149450 of 159568 results.
| Sigma Cat.No. | Description |
|---|---|
| SRP2011 | TFIIH, p62 subunit human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2012 | TFIID, native complex human ≥70% (SDS-PAGE) |
| SRP2013 | RNA Polymerase II, C-terminal human recombinant, expressed in E. coli, ≥85% (SDS-PAGE) |
| SRP2014 | RNA Polymerase II, p33 subunit human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2015 | RNA Polymerase II, p14.5 subunit human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2016 | GAL4 [(1-147) - AH] from Saccharomyces cerevisiae recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2017 | GAL4 [(1-147) + VP16 (411-490)] from Saccharomyces cerevisiae human herpesvirus 2 recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2018 | GAL4 [(1-147) + E1A (121-223)] from Saccharomyces cerevisiae canine adenovirus recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2019 | RXR, α human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2020 | TR, β 1 isoform human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2021 | Dr1 (NC2b, 19 kDa) human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2022 | PC4, wild type human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2023 | PC4, F77P mutant human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2024 | PC4, serine mutations human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2025 | p52 human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2026 | p75 human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2027 | E2F-1 (RBAP-1) human recombinant, expressed in insect cells, ≥70% (SDS-PAGE) |
| SRP2028 | TFIIA, reconstituted human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2029 | Sp1 GC-box binding protein human ≥70% (SDS-PAGE) |
| SRP2030 | Sp1 GC-box binding protein human recombinant, expressed in insect cells, ≥75% (SDS-PAGE) |
| SRP2031 | CTF1 human recombinant, expressed in insect cells, ≥70% (SDS-PAGE) |
| SRP2032 | Topo I (C651-765) (C terminal domain) human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2033 | Topo I (197-651) (core domain) human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2034 | Topo I (N1-197) (NTD) human recombinant, expressed in insect cells, ≥85% (SDS-PAGE) |
| SRP2035 | Topo I (Y723F) (mt Y723F) human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2036 | BRG1, wild type human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2037 | BRG1-mt, K798R human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2039 | FXR (Farnesoid- recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2040 | LXR, α human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2041 | LXR, β human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2042 | LXRα-ligand binding domain (215-667) human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2043 | PPAR, α human recombinant, expressed in E. coli, ≥75% (SDS-PAGE) |
| SRP2044 | PPAR, β human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2045 | PPAR, γ human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2046 | Thyroid Hormone receptor,α1 human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2047 | RXR, β human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2048 | RAR, α human recombinant, expressed in insect cells, ≥70% (SDS-PAGE) |
| SRP2049 | RAR, γ human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2050 | RAR, β human recombinant, expressed in E. coli, ≥75% (SDS-PAGE) |
| SRP2051 | HMG1, native from calf thymus ≥85% (SDS-PAGE) |
| SRP2052 | p75-CTR (C-terminal region) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2053 | USF1 human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2054 | PPARα, ligand binding domain (170-468) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2055 | PPARβ, ligand binding domain (165-441) human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2056 | PPARγ, ligand binding domain (165-441) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2057 | LXR β-ligand binding domain (211-461) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2058 | FXR-ligand binding domain (222-472) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2059 | RARα-ligand binding domain (154-462) human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2060 | RAR β-ligand binding domain (173-409) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2061 | RAR γ-ligand binding domain (150-417) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |